- The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study
-
Moon JS, Park IR, Kim SS, Kim HS, Kim NH, Kim SG, Ko SH, Lee JH, Lee I, Lee BK, Won KC
- KMID: 2548158
- Diabetes Metab J.
- 2023 Nov;47(6):818-825.
- doi: 10.4093/dmj.2023.0171
Background: To investigate the efficacy and safety of moderate-intensity rosuvastatin/ezetimibe combination compared to highintensity rosuvastatin in high atherosclerotic cardiovascular disease (ASCVD) risk patients with type 2 diabetes mellitus (T2DM). Methods: This... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension
-
Moon JS, Park IR, Kim HJ, Chung CH, Won KC, Han KA, Park CY, Won JC, Kim DJ, Koh GP, Kim ES, Yu JM, Hong EG, Lee CB, Yoon KH
- KMID: 2548157
- Diabetes Metab J.
- 2023 Nov;47(6):808-817.
- doi: 10.4093/dmj.2022.0387
Background: This study investigates the long-term efficacy and safety of evogliptin add-on therapy in patients with inadequately controlled type 2 diabetes mellitus (T2DM) previously received dapagliflozin and metformin (DAPA/MET) combination. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies
-
Mesinovic J, Fyfe JJ, Talevski J, Wheeler MJ, Leung GK, George ES, Hunegnaw MT, Glavas C, Jansons P, Daly RM, Scott D
- KMID: 2548149
- Diabetes Metab J.
- 2023 Nov;47(6):719-742.
- doi: 10.4093/dmj.2023.0112
Type 2 diabetes mellitus (T2DM) and sarcopenia (low skeletal muscle mass and function) share a bidirectional relationship. The prevalence of these diseases increases with age and they share common risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes Mellitus
-
Lee DY, Kim N, Jung I, Park SY, Yu JH, Seo JA, Kim J, Kim KJ, Kim NH, Yoo HJ, Kim SG, Choi KM, Baik SH, Park SM, Kim NH
- KMID: 2548159
- Diabetes Metab J.
- 2023 Nov;47(6):826-836.
- doi: 10.4093/dmj.2022.0273
Background: There was limited evidence to evaluate the association between lifestyle habits and continuous glucose monitoring (CGM) metrics. Thus, we aimed to depict the behavioral and metabolic determinants of CGM... -
- CITED
-
- Close
- SHARE
-
- Close
- Differential Impact of Obesity on the Risk of Diabetes Development in Two Age Groups: Analysis from the National Health Screening Program
-
Yoo TK, Han KD, Kim YH, Nam GE, Park SH, Rhee EJ, Lee WY
- KMID: 2548161
- Diabetes Metab J.
- 2023 Nov;47(6):846-858.
- doi: 10.4093/dmj.2022.0242
Background: The effect of obesity on the development of type 2 diabetes mellitus (DM) in different age groups remains unclear. We assessed the impact of obesity on the development of... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of on-Statin Lipid and Lipoprotein Levels for the Prediction of First Cardiovascular Event in Type 2 Diabetes Mellitus
-
Kim JY, Choi J, Kim SG, Kim NH
- KMID: 2548160
- Diabetes Metab J.
- 2023 Nov;47(6):837-845.
- doi: 10.4093/dmj.2022.0217
Background: A substantial cardiovascular disease risk remains even after optimal statin therapy. Comparative predictiveness of major lipid and lipoprotein parameters for cardiovascular events in patients with type 2 diabetes mellitus... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial
-
Han KA, Kim YH, Kim DM, Lee BW, Chon S, Sohn TS, Jeong IK, Hong EG, Son JW, Nah JJ, Song HR, Cho SI, Cho SA, Yoon KH
- KMID: 2548156
- Diabetes Metab J.
- 2023 Nov;47(6):796-807.
- doi: 10.4093/dmj.2022.0315
Background: Enavogliflozin is a novel sodium-glucose cotransporter-2 inhibitor currently under clinical development. This study evaluated the efficacy and safety of enavogliflozin as an add-on to metformin in Korean patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- The Benefits Of Continuous Glucose Monitoring In Pregnancy
-
Yoo JH, Kim JH
- KMID: 2546978
- Endocrinol Metab.
- 2023 Oct;38(5):472-481.
- doi: 10.3803/EnM.2023.1805
Previous studies have consistently demonstrated the positive effects of continuous glucose monitoring (CGM) on glycemic outcomes and complications of diabetes in people with type 1 diabetes. Guidelines now consider CGM... -
- CITED
-
- Close
- SHARE
-
- Close
- Coronary Artery Calcium Score as a Sensitive Indicator of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus: A Long-Term Cohort Study
-
Koo DJ, Lee MY, Moon SJ, Kwon H, Lee SM, Park SE, Park CY, Lee WY, Oh KW, Cho SR, Jeong YH, Rhee EJ
- KMID: 2546987
- Endocrinol Metab.
- 2023 Oct;38(5):568-577.
- doi: 10.3803/EnM.2023.1770
Background: Coronary artery calcium score (CACS) has become an important tool for evaluating cardiovascular disease (CVD). This study evaluated the significance of CACS for future CVD through more than 10... -
- CITED
-
- Close
- SHARE
-
- Close
- Intake of Fruit and Glycemic Control in Korean Patients with Diabetes Mellitus Using the Korea National Health and Nutrition Examination Survey
-
Yoon E, Bae JC, Suh S
- KMID: 2546984
- Endocrinol Metab.
- 2023 Oct;38(5):538-544.
- doi: 10.3803/EnM.2023.1730
Background: Despite the well-recognized health benefits of fresh fruit consumption, there is still substantial uncertainty about its potential effects on glycemic control in patients with type 2 diabetes mellitus (T2DM). Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- 2023 Clinical Practice Guidelines for Diabetes: Management of Cardiovascular Risk Factors
-
Yang YS
- KMID: 2546630
- J Korean Diabetes.
- 2023 Sep;24(3):135-140.
- doi: 10.4093/jkd.2023.24.3.135
To prevent cardiovascular disease (CVD), which is one of the ultimate goals in the management of patients with diabetes, it is important to control not only hyperglycemia, but also modifiable... -
- CITED
-
- Close
- SHARE
-
- Close
- 2023 Clinical Practice Guidelines for Diabetes: Recommendations for Pharmacological Treatment of Type 2 Diabetes
-
Noh J
- KMID: 2546629
- J Korean Diabetes.
- 2023 Sep;24(3):127-134.
- doi: 10.4093/jkd.2023.24.3.127
The 2023 clinical practice guidelines for diabetes in Korea are reviewed and updated biennially by the Committee of Clinical Practice Guidelines of the Korean Diabetes Association based on the latest... -
- CITED
-
- Close
- SHARE
-
- Close
- 2023 Clinical Practice Guidelines for Diabetes
-
Moon MK
- KMID: 2546628
- J Korean Diabetes.
- 2023 Sep;24(3):120-126.
- doi: 10.4093/jkd.2023.24.3.120
The Committee on Clinical Practice Guidelines of the Korean Diabetes Association updated the previous clinical practice guidelines for Korean adults with diabetes and prediabetes and published the eighth edition in... -
- CITED
-
- Close
- SHARE
-
- Close
- Low Household Income Status and Death from Pneumonia in People with Type 2 Diabetes Mellitus: A Nationwide Study
-
Lee YB, Park SH, Lee Kn, Kim B, Kwon SY, Park J, Kim G, Jin SM, Hur KY, Han K, Kim JH
- KMID: 2546126
- Diabetes Metab J.
- 2023 Sep;47(5):682-692.
- doi: 10.4093/dmj.2022.0184
Background: We explored the risk of death from pneumonia according to cumulative duration in low household income state (LHIS) among adults with type 2 diabetes mellitus (T2DM). Methods: Using Korean National... -
- CITED
-
- Close
- SHARE
-
- Close
- Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
-
Scherbak NN, Kruse R, Nyström T, Jendle J
- KMID: 2546125
- Diabetes Metab J.
- 2023 Sep;47(5):668-681.
- doi: 10.4093/dmj.2022.0342
Background: Diabetes is a chronic disease with several long-term complications. Several glucose-lowering drugs are used to treat type 2 diabetes mellitus (T2DM), e.g., glimepiride and liraglutide, in which both having... -
- CITED
-
- Close
- SHARE
-
- Close
- CycloZ Improves Hyperglycemia and Lipid Metabolism by Modulating Lysine Acetylation in KK-Ay Mice
-
Jeon J, Lee D, Kim B, Park BY, Oh CJ, Kim MJ, Jeon JH, Lee IK, Park O, Baek S, Lim CW, Ryu D, Fang S, Auwerx J, Kim KT, Jung HY
- KMID: 2546124
- Diabetes Metab J.
- 2023 Sep;47(5):653-667.
- doi: 10.4093/dmj.2022.0244
Background: CycloZ, a combination of cyclo-His-Pro and zinc, has anti-diabetic activity. However, its exact mode of action remains to be elucidated. Methods: KK-Ay mice, a type 2 diabetes mellitus (T2DM) model,... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Pancreatic Cancer and Use of Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes: A Propensity Score-Matching Analysis
-
Kim MK, Han K, Kwon HS, Yoo SJ
- KMID: 2545275
- Endocrinol Metab.
- 2023 Aug;38(4):426-435.
- doi: 10.3803/EnM.2023.1737
Background: The effects of dipeptidyl peptidase 4 (DPP-4) inhibitors over the course of long-term treatment remain unclear, and concerns have been raised regarding the role of DPP-4 inhibitors in carcinogenesis... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of coffee consumption with type 2 diabetes and glycemic traits: a Mendelian randomization study
-
Cho HJ, Okekunle AP, Yie GE, Youn J, Kang M, Jin T, Sung J, Lee JE
- KMID: 2545192
- Nutr Res Pract.
- 2023 Aug;17(4):789-802.
- doi: 10.4162/nrp.2023.17.4.789
BACKGROUND/OBJECTIVES: Habitual coffee consumption was inversely associated with type 2 diabetes (T2D) and hyperglycemia in observational studies, but the causality of the association remains uncertain. This study tested a causal... -
- CITED
-
- Close
- SHARE
-
- Close
- Change Profiles and Functional Targets of MicroRNAs in Type 2 Diabetes Mellitus Patients with Obesity
-
Lu G, Gao H, Dong Z, Jiang S, Hu R, Wang C
- KMID: 2544734
- Diabetes Metab J.
- 2023 Jul;47(4):559-570.
- doi: 10.4093/dmj.2022.0226
Background: MicroRNAs (miRNAs) exert an essential contribution to obesity and type 2 diabetes mellitus (T2DM). This study aimed to investigate the differences of miRNAs in the presence and absence of... -
- CITED
-
- Close
- SHARE
-
- Close
- Glycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKD
-
Heo GY, Koh HB, Kim HW, Park JT, Yoo TH, Kang SW, Kim J, Kim SW, Kim YH, Sung SA, Oh KH, Han SH
- KMID: 2544732
- Diabetes Metab J.
- 2023 Jul;47(4):535-546.
- doi: 10.4093/dmj.2022.0112
Background: The optimal level of glycosylated hemoglobin (HbA1c) to prevent adverse clinical outcomes is unknown in patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM). Methods: We analyzed... -
- CITED
-
- Close
- SHARE
-
- Close
